Non-opioid Pain Patches Market Report

Global Non-opioid Pain Patches Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：193
  • REPORT CODE：GMM775043
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Non-opioid Pain Patches market report explains the definition, types, applications, major countries, and major players of the Non-opioid Pain Patches market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • GlaxoSmithKline

    • Pfizer

    • Hisamitsu Pharmaceutical

    • Endo International

    • Novartis AG

    • Allergan PLC

    • Acorda Therapeutics

    • Teva Pharmaceutical Industries

    • IBSA Institut Biochimque SA

    • Mylan NV

    • Teikoku Seiyaku

    • TEH SENG Pharmaceutical

    By Type:

    • Lidocaine Patch

    • Diclofenac Patch

    • Methyl Salicylate Patch

    • Capsaicin Patch

    • Ketoprofen Patch

    • Other

    By End-User:

    • Hospital Pharmacies

    • Independent Pharmacies & Drug Stores

    • Online Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Non-opioid Pain Patches Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Non-opioid Pain Patches Outlook to 2028- Original Forecasts

    • 2.2 Non-opioid Pain Patches Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Non-opioid Pain Patches Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Non-opioid Pain Patches Market- Recent Developments

    • 6.1 Non-opioid Pain Patches Market News and Developments

    • 6.2 Non-opioid Pain Patches Market Deals Landscape

    7 Non-opioid Pain Patches Raw Materials and Cost Structure Analysis

    • 7.1 Non-opioid Pain Patches Key Raw Materials

    • 7.2 Non-opioid Pain Patches Price Trend of Key Raw Materials

    • 7.3 Non-opioid Pain Patches Key Suppliers of Raw Materials

    • 7.4 Non-opioid Pain Patches Market Concentration Rate of Raw Materials

    • 7.5 Non-opioid Pain Patches Cost Structure Analysis

      • 7.5.1 Non-opioid Pain Patches Raw Materials Analysis

      • 7.5.2 Non-opioid Pain Patches Labor Cost Analysis

      • 7.5.3 Non-opioid Pain Patches Manufacturing Expenses Analysis

    8 Global Non-opioid Pain Patches Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Non-opioid Pain Patches Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Non-opioid Pain Patches Export by Region (Top 10 Countries) (2017-2028)

    9 Global Non-opioid Pain Patches Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-opioid Pain Patches Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lidocaine Patch Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diclofenac Patch Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Methyl Salicylate Patch Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Capsaicin Patch Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ketoprofen Patch Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-opioid Pain Patches Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Independent Pharmacies & Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Non-opioid Pain Patches Market Analysis and Outlook till 2022

    • 10.1 Global Non-opioid Pain Patches Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Non-opioid Pain Patches Consumption (2017-2022)

      • 10.2.2 Canada Non-opioid Pain Patches Consumption (2017-2022)

      • 10.2.3 Mexico Non-opioid Pain Patches Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.2 UK Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.3 Spain Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.4 Belgium Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.5 France Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.6 Italy Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.7 Denmark Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.8 Finland Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.9 Norway Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.10 Sweden Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.11 Poland Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.12 Russia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.3.13 Turkey Non-opioid Pain Patches Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.2 Japan Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.3 India Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.4 South Korea Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.5 Pakistan Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.6 Bangladesh Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.7 Indonesia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.8 Thailand Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.9 Singapore Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.10 Malaysia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.11 Philippines Non-opioid Pain Patches Consumption (2017-2022)

      • 10.4.12 Vietnam Non-opioid Pain Patches Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.2 Colombia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.3 Chile Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.4 Argentina Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.5 Venezuela Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.6 Peru Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.7 Puerto Rico Non-opioid Pain Patches Consumption (2017-2022)

      • 10.5.8 Ecuador Non-opioid Pain Patches Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Non-opioid Pain Patches Consumption (2017-2022)

      • 10.6.2 Kuwait Non-opioid Pain Patches Consumption (2017-2022)

      • 10.6.3 Oman Non-opioid Pain Patches Consumption (2017-2022)

      • 10.6.4 Qatar Non-opioid Pain Patches Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Non-opioid Pain Patches Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Non-opioid Pain Patches Consumption (2017-2022)

      • 10.7.2 South Africa Non-opioid Pain Patches Consumption (2017-2022)

      • 10.7.3 Egypt Non-opioid Pain Patches Consumption (2017-2022)

      • 10.7.4 Algeria Non-opioid Pain Patches Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Non-opioid Pain Patches Consumption (2017-2022)

      • 10.8.2 New Zealand Non-opioid Pain Patches Consumption (2017-2022)

    11 Global Non-opioid Pain Patches Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Non-opioid Pain Patches Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Non-opioid Pain Patches Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline

      • 11.2.1 GlaxoSmithKline Company Details

      • 11.2.2 GlaxoSmithKline Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline Non-opioid Pain Patches Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline Non-opioid Pain Patches Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Pfizer

      • 11.3.1 Pfizer Company Details

      • 11.3.2 Pfizer Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Pfizer Non-opioid Pain Patches Main Business and Markets Served

      • 11.3.4 Pfizer Non-opioid Pain Patches Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Hisamitsu Pharmaceutical

      • 11.4.1 Hisamitsu Pharmaceutical Company Details

      • 11.4.2 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Main Business and Markets Served

      • 11.4.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Endo International

      • 11.5.1 Endo International Company Details

      • 11.5.2 Endo International Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Endo International Non-opioid Pain Patches Main Business and Markets Served

      • 11.5.4 Endo International Non-opioid Pain Patches Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis AG

      • 11.6.1 Novartis AG Company Details

      • 11.6.2 Novartis AG Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis AG Non-opioid Pain Patches Main Business and Markets Served

      • 11.6.4 Novartis AG Non-opioid Pain Patches Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Allergan PLC

      • 11.7.1 Allergan PLC Company Details

      • 11.7.2 Allergan PLC Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Allergan PLC Non-opioid Pain Patches Main Business and Markets Served

      • 11.7.4 Allergan PLC Non-opioid Pain Patches Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Acorda Therapeutics

      • 11.8.1 Acorda Therapeutics Company Details

      • 11.8.2 Acorda Therapeutics Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Acorda Therapeutics Non-opioid Pain Patches Main Business and Markets Served

      • 11.8.4 Acorda Therapeutics Non-opioid Pain Patches Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Teva Pharmaceutical Industries

      • 11.9.1 Teva Pharmaceutical Industries Company Details

      • 11.9.2 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Main Business and Markets Served

      • 11.9.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 IBSA Institut Biochimque SA

      • 11.10.1 IBSA Institut Biochimque SA Company Details

      • 11.10.2 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Main Business and Markets Served

      • 11.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Mylan NV

      • 11.11.1 Mylan NV Company Details

      • 11.11.2 Mylan NV Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Mylan NV Non-opioid Pain Patches Main Business and Markets Served

      • 11.11.4 Mylan NV Non-opioid Pain Patches Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Teikoku Seiyaku

      • 11.12.1 Teikoku Seiyaku Company Details

      • 11.12.2 Teikoku Seiyaku Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Teikoku Seiyaku Non-opioid Pain Patches Main Business and Markets Served

      • 11.12.4 Teikoku Seiyaku Non-opioid Pain Patches Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 TEH SENG Pharmaceutical

      • 11.13.1 TEH SENG Pharmaceutical Company Details

      • 11.13.2 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Main Business and Markets Served

      • 11.13.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Non-opioid Pain Patches Market Outlook by Types and Applications to 2028

    • 12.1 Global Non-opioid Pain Patches Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Lidocaine Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Diclofenac Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Methyl Salicylate Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Capsaicin Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Ketoprofen Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Non-opioid Pain Patches Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Independent Pharmacies & Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Non-opioid Pain Patches Market Analysis and Outlook to 2028

    • 13.1 Global Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.2.2 Canada Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.2 UK Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.3 Spain Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.5 France Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.6 Italy Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.8 Finland Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.9 Norway Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.11 Poland Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.12 Russia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.2 Japan Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.3 India Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.3 Chile Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.6 Peru Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.6.3 Oman Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Non-opioid Pain Patches Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Non-opioid Pain Patches Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Non-opioid Pain Patches Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Non-opioid Pain Patches

    • Figure of Non-opioid Pain Patches Picture

    • Table Global Non-opioid Pain Patches Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Non-opioid Pain Patches Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Lidocaine Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Diclofenac Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Methyl Salicylate Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Capsaicin Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Ketoprofen Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Independent Pharmacies & Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Table North America Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure United States Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Canada Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Mexico Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table Europe Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure Germany Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure UK Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Spain Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Belgium Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure France Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Italy Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Denmark Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Finland Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Norway Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Sweden Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Poland Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Russia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Turkey Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table APAC Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure China Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure India Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Thailand Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Singapore Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Philippines Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table South America Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure Brazil Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Colombia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Chile Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Argentina Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Peru Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table GCC Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure Bahrain Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Oman Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Qatar Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table Africa Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure Nigeria Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure South Africa Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Egypt Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure Algeria Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table Oceania Non-opioid Pain Patches Consumption by Country (2017-2022)

    • Figure Australia Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Non-opioid Pain Patches Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Non-opioid Pain Patches Main Business and Markets Served

    • Table Johnson & Johnson Non-opioid Pain Patches Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Non-opioid Pain Patches Main Business and Markets Served

    • Table GlaxoSmithKline Non-opioid Pain Patches Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Non-opioid Pain Patches Main Business and Markets Served

    • Table Pfizer Non-opioid Pain Patches Product Portfolio

    • Table Hisamitsu Pharmaceutical Company Details

    • Table Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hisamitsu Pharmaceutical Non-opioid Pain Patches Main Business and Markets Served

    • Table Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolio

    • Table Endo International Company Details

    • Table Endo International Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo International Non-opioid Pain Patches Main Business and Markets Served

    • Table Endo International Non-opioid Pain Patches Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Non-opioid Pain Patches Main Business and Markets Served

    • Table Novartis AG Non-opioid Pain Patches Product Portfolio

    • Table Allergan PLC Company Details

    • Table Allergan PLC Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan PLC Non-opioid Pain Patches Main Business and Markets Served

    • Table Allergan PLC Non-opioid Pain Patches Product Portfolio

    • Table Acorda Therapeutics Company Details

    • Table Acorda Therapeutics Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acorda Therapeutics Non-opioid Pain Patches Main Business and Markets Served

    • Table Acorda Therapeutics Non-opioid Pain Patches Product Portfolio

    • Table Teva Pharmaceutical Industries Company Details

    • Table Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Non-opioid Pain Patches Main Business and Markets Served

    • Table Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolio

    • Table IBSA Institut Biochimque SA Company Details

    • Table IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBSA Institut Biochimque SA Non-opioid Pain Patches Main Business and Markets Served

    • Table IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolio

    • Table Mylan NV Company Details

    • Table Mylan NV Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NV Non-opioid Pain Patches Main Business and Markets Served

    • Table Mylan NV Non-opioid Pain Patches Product Portfolio

    • Table Teikoku Seiyaku Company Details

    • Table Teikoku Seiyaku Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teikoku Seiyaku Non-opioid Pain Patches Main Business and Markets Served

    • Table Teikoku Seiyaku Non-opioid Pain Patches Product Portfolio

    • Table TEH SENG Pharmaceutical Company Details

    • Table TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEH SENG Pharmaceutical Non-opioid Pain Patches Main Business and Markets Served

    • Table TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolio

    • Figure Global Lidocaine Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diclofenac Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Methyl Salicylate Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsaicin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ketoprofen Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Independent Pharmacies & Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Table North America Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure United States Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure Germany Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure China Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure Brazil Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Non-opioid Pain Patches Consumption Forecast by Country (2022-2028)

    • Figure Australia Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Non-opioid Pain Patches Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US